tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Income Statement

Compare
488 Followers

4D Molecular Therapeutics Income Statement

Last quarter (Q3 2025), 4D Molecular Therapeutics's total revenue was $90.00K, an increase of 2900.00% from the same quarter last year. In Q3, 4D Molecular Therapeutics's net income was $-56.88M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 37.00K$ 20.72M$ 3.13M$ 18.04M$ 13.61M
Gross Profit
$ 37.00K$ -76.37M$ -77.12M$ -43.32M$ -39.43M
Operating Expenses
$ 187.88M$ 36.49M$ 32.91M$ 28.01M$ 17.24M
Depreciation and Amortization
$ 6.71M$ 4.20M$ 2.40M$ 1.52M$ 1.44M
EBITDA
$ -181.14M$ -108.66M$ -107.63M$ -69.81M$ -55.22M
Operating Income
$ -187.84M$ -112.87M$ -110.03M$ -71.33M$ -56.66M
Other Income/Expenses
$ 26.97M$ 12.03M$ 2.54M$ 16.00K$ -29.00K
Pretax Income
$ -160.87M$ -100.84M$ -107.49M$ -71.32M$ -56.69M
Net Income
$ -160.87M$ -100.84M$ -107.49M$ -71.32M$ -56.69M
Per Share Metrics
Basic EPS
$ -2.98$ -2.58$ -3.12$ -2.46$ -2.12
Diluted EPS
$ -2.98$ -2.58$ -3.12$ -2.46$ -2.12
Weighted Average Shares Outstanding
53.94M 39.13M 32.35M 27.73M 26.68M
Weighted Average Shares Outstanding (Diluted)
53.94M 39.13M 32.35M 27.73M 26.68M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History